Cited by 116Parkinson's Disease Mechanisms and TreatmentsLysosomal Storage Disorders ResearchNeurological diseases and metabolism

Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease

Open access
Oji, Yutaka, Hatano, Taku, Ueno, Shin-Ichi, Funayama, Manabu, Ishikawa, Kei-ichi, Okuzumi, Ayami, Noda, Sachiko, Sato, Shigeto +24 more·2020·Brain

Abstract

Recently, the genetic variability in lysosomal storage disorders has been implicated in the pathogenesis of Parkinson’s disease. Here, we found that variants in prosaposin (PSAP), a rare causative gene of various types of lysosomal storage disorders, are linked to Parkinson’s disease. Genetic mutation screening revealed three pathogenic mutations in the saposin D domain of PSAP from three families with autosomal dominant Parkinson’s disease. Whole-exome sequencing revealed no other variants in previously identified Parkinson’s disease-causing or lysosomal storage disorder-causing genes. A case-control association study found two variants in the intronic regions of the PSAP saposin D domain (rs4747203 and rs885828) in sporadic Parkinson’s disease had significantly higher allele frequencies in a combined cohort of Japan and Taiwan. We found the abnormal accumulation of autophagic vacuoles, impaired autophagic flux, altered intracellular localization of prosaposin, and an aggregation of α-synuclein in patient-derived skin fibroblasts or induced pluripotent stem cell-derived dopaminergic neurons. In mice, a Psap saposin D mutation caused progressive motor decline and dopaminergic neurodegeneration. Our data provide novel genetic evidence for the involvement of the PSAP saposin D domain in Parkinson’s disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awaa064

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Autophagy plays an important role in maintaining redox homeostasis in cells.

    “Many autophagy-related genes were also common hits in the two screens (Fig. 2 d,e), such as WIPI2, ATG9A, ATG13, ATG14, and BECN1, suggesting an important role of autophagy in maintaining redox homeostasis in cells, as reported in previous studies31–33.”
  • Many autophagy-related genes (WIPI2, ATG9A, ATG13, ATG14, BECN1) were common hits in the ROS and lipid peroxidation screens.

    “Many autophagy-related genes were also common hits in the two screens (Fig. 2 d,e), such as WIPI2, ATG9A, ATG13, ATG14, and BECN1, suggesting an important role of autophagy in maintaining redox homeostasis in cells, as reported in previous studies31–33.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, et al. Alpha-synuclein RT-QuIC in the CSF of patients with alpha- synucleinopathies. Ann Clin Transl Neurol 2016; 3: 812-8.
  2. Mutoh T, Naoi N, Takahashi A, Hoshino M, Nagai Y, Nagatsu T. Atypical adult GM1 gangliosidosis: biochemical comparison with other forms of primary beta-galactosidase deficiency. Neurology 1986; 36: 1237-41.

Cited by

Sorted by citations

Authors
Oji, Y., Hatano, T., Ueno, S.-I., Funayama, M., Ishikawa, K.-I., Okuzumi, A., Noda, S., Sato, S., Satake, W., Toda, T., Li, Y., Hino-Takai, T., Kakuta, S., Tsunemi, T., Yoshino, H., Nishioka, K., Hattori, T., Mizutani, Y., Mutoh, T., Yokochi, F., Ichinose, Y., Koh, K., Shindo, K., Takiyama, Y., Hamaguchi, T., Yamada, M., Farrer, M. J., Uchiyama, Y., Akamatsu, W., Wu, Y.-R., Matsuda, J., & Hattori, N.
Affiliations
  • Juntendo University (JP)
  • The University of Tokyo (JP)
  • Kawasaki Medical School (JP)
  • Department of Neurology, Hommachi Neurological Clinic, Nagoya, Japan
  • Fujita Health University (JP)
  • Tokyo Metropolitan Neurological Hospital (JP)
  • University of Yamanashi (JP)
  • Kanazawa University (JP)
  • University of British Columbia (CA)
  • Chang Gung University (TW)
Corresponding author
Hattori, Nobutaka
Venue
Brain
Published
2020-03-23
Volume
143
Issue
4
Pages
1190-1205
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W3012573239
Cited by
116
References
61
Citations by year
2026: 18 · 2025: 15 · 2024: 16 · 2023: 15 · 2022: 18 · 2021: 18 · 2020: 15
FWCI
7.14
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Strategic Research Foundation at Private Universities
  • Japan Society for the Promotion of Science
  • KAKENHI (JP16H07184, JP19K17019, JP25461290, JP24390224, JP18H04043)
  • Japan Agency for Medical Research and Development
  • Advanced Research & Development Programs for Medical Innovation
  • Strategic Research Program for Brain Sciences (18bm0804003, 19bm0804003, 18km0405206, 19km0405206, 19dm0107156, 19ek0109358, 19ek0109393, 19dm0207070)
  • Grants-in Aid from the Research Committee of CNS Degenerative Disease
  • Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health, Labour
  • Welfare Sciences Research Grants
  • Ministry of Health, Labour and Welfare
  • Canadian Institutes of Health Operating Grant (FRN 123275)
  • Minister of Science and Technology (MOST 107-2314-B-182A-045-MY2)
  • Chang Gung Memorial Hospital (CMRPG3H0313)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
Parkinson's disease, prosaposin, lysosomal storage disease, genetic variants, autosomal dominant Parkinson's disease, sporadic Parkinson's disease, autophagic flux, autophagosomes, alpha-synuclein aggregation, dopaminergic neuron loss, motor function decline, genetic association
MeSH terms
Aged, Animals, Female, Humans, Male, Mice, Mutant Strains, Middle Aged, Nerve Degeneration, Parkinson Disease, Case-Control Studies, Genetic Predisposition to Disease, Saposins, Mice, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review